This observation is in accordance with Hussein et al. [37] whereby they observed a marked increase in cfDNA integrity in breast cancer patients with HER2 amplification which may be attributed to the increased proliferation associated with the HER2 subtype. This evidence concerns the gene ERBB2 and breast cancer.